Although lung ultrasound (LUS) is considered non-invasive in nature, handling and probe pressure may provoke pain and transient physiological changes in preterm infants. The aim of this study was to determine whether oral sucrose combined with a pacifier reduces procedural pain and stress in preterm infants undergoing bedside LUS. A two-arm randomized controlled trial was conducted between November 2020 and January 2023. Preterm infants undergoing LUS were randomized to receive either oral sucrose-plus-pacifier or pacifier-alone, administered 2 min before the scan. Pain was evaluated using the premature infant pain profile (PIPP) at four time points: baseline (30 s before intervention), 30 s into scanning, midpoint of the scan, and 30 s post-procedure. Physiological parameters (heart rate, oxygen saturation, and apneic episodes) and duration of the procedure were recorded. Group differences in PIPP scores were analyzed using repeated-measures ANOVA. Out of 60 infants enrolled, 30 infants were randomized in each group with data available on 29 infants in the sucrose-plus-pacifier group and 27 in the pacifier-alone group. Baseline demographics and clinical characteristics were comparable between groups. No statistically significant differences were observed in PIPP scores and physiological parameters at any time point between groups. Repeated-measures ANOVA showed a significant change in PIPP scores across procedural phases (p < 0.0001), with no differences between groups (p = 0.16) or group-by-phase interaction, indicating similar PIPP score trajectories in both groups (p = 0.21). Conclusion: Among preterm infants, sucrose did not add benefit to pacifier-alone for reducing procedural pain and stress during lung ultrasound.Trial registration: NCT05717088.<Table Float="No" ID="Taba"> <tgroup cols="2"> <colspec align="left" colname="c1" colnum="1" /> <colspec align="left" colname="c2" colnum="2" /> <tbody> <row> <entry align="left" nameend="c2" namest="c1"> What is Known • Lung ultrasound (LUS) is a bedside, radiation-free imaging modality increasingly used in preterm infants, but probe pressure and handling may still provoke mild procedural discomfort and physiological changes. • Oral sucrose is an established non-pharmacologic analgesic for painful neonatal procedures; however, its benefit during minimally invasive procedures such as LUS remains uncertain. </entry> </row> <row> <entry align="left" nameend="c2" namest="c1"> What is New • In this randomized controlled trial, oral sucrose did not provide additional analgesic benefit beyond pacifier use alone during bedside LUS in preterm infants. • These findings suggest that non-nutritive sucking alone may be sufficient for comfort during LUS, supporting its classification as a minimally distressing neonatal bedside procedure. </entry> </row> </tbody> </tgroup> </Table>

Efficacy of oral sucrose for preterm infants undergoing point-of-care lung ultrasound: a randomized assessor-blinded controlled trial

期刊论文
发表日期：

2026年3月25日

查看全文

Mohamed Elkhouli,
Nada Mohsen,
Thanaa Elhanafy,
Jenna Ibrahim,
Charles Cheng,
Seungwoo Lee,
Carol Cheng,
Anna Taddio,
Vibhuti Shah,
Adel Mohamed

摘要

Although lung ultrasound (LUS) is considered non-invasive in nature, handling and probe pressure may provoke pain and transient physiological changes in preterm infants. The aim of this study was to determine whether oral sucrose combined with a pacifier reduces procedural pain and stress in preterm infants undergoing bedside LUS. A two-arm randomized controlled trial was conducted between November 2020 and January 2023. Preterm infants undergoing LUS were randomized to receive either oral sucrose-plus-pacifier or pacifier-alone, administered 2 min before the scan. Pain was evaluated using the premature infant pain profile (PIPP) at four time points: baseline (30 s before intervention), 30 s into scanning, midpoint of the scan, and 30 s post-procedure. Physiological parameters (heart rate, oxygen saturation, and apneic episodes) and duration of the procedure were recorded. Group differences in PIPP scores were analyzed using repeated-measures ANOVA. Out of 60 infants enrolled, 30 infants were randomized in each group with data available on 29 infants in the sucrose-plus-pacifier group and 27 in the pacifier-alone group. Baseline demographics and clinical characteristics were comparable between groups. No statistically significant differences were observed in PIPP scores and physiological parameters at any time point between groups. Repeated-measures ANOVA showed a significant change in PIPP scores across procedural phases (p < 0.0001), with no differences between groups (p = 0.16) or group-by-phase interaction, indicating similar PIPP score trajectories in both groups (p = 0.21).

Conclusion: Among preterm infants, sucrose did not add benefit to pacifier-alone for reducing procedural pain and stress during lung ultrasound.

Trial registration: NCT05717088.

What is Known

• Lung ultrasound (LUS) is a bedside, radiation-free imaging modality increasingly used in preterm infants, but probe pressure and handling may still provoke mild procedural discomfort and physiological changes.

• Oral sucrose is an established non-pharmacologic analgesic for painful neonatal procedures; however, its benefit during minimally invasive procedures such as LUS remains uncertain.

What is New

• In this randomized controlled trial, oral sucrose did not provide additional analgesic benefit beyond pacifier use alone during bedside LUS in preterm infants.

• These findings suggest that non-nutritive sucking alone may be sufficient for comfort during LUS, supporting its classification as a minimally distressing neonatal bedside procedure.